United States Biotechnology & Medical Research

WAVE Life Sciences Ltd (WVE)

Track

Track

WAVE Life Sciences experienced six insider trading transactions over the past ninety days, all involving sales. These disposals occurred following a recent earnings report that missed expectations. The stock price has declined 22.2% during this period, currently trading near its fifty-two week low.
Ticker: WVE Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for WAVE Life Sciences Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
Rawcliffe Adrian Non-Executive Director
Transaction date
Planned sale
Price
46.34
Quantity 7,410 -25.5%
Value US$3,132,121
2.9
ADRIAN G RAWCLIFFE Director Non-Executive Director
Transaction date
Proposed sale
Price
114.95
Quantity 2,201
Value US$2,152,124
1.4
TAKANASHI KEN Non-Executive Director
Transaction date
Planned sale
Price
259.89
Quantity 18,587 -28.0%
Value US$3,106,211
Wagner Heidi L Non-Executive Director
Transaction date
Planned sale
Price
6.01
Quantity 7,000 -13.5%
Value US$42,070
Tan Aik Na Non-Executive Director
Transaction date
Planned sale
Price
6.01
Quantity 432 -1.7%
Value US$2,596
HEIDI L WAGNER Director Non-Executive Director
Transaction date
Proposed sale
Price
6.07
Quantity 7,000
Value US$42,490
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.50
Quantity 971,091 +3.7%
Value US$6,312,092
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.43
Quantity 2,495,623 +10.6%
Value US$16,046,856
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.38
Quantity 351,224 +1.5%
Value US$2,240,809
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.06
Quantity 4,954,558 +27.2%
Value US$30,024,621
3.2
Francis Chris See Remarks Officer
Transaction date
Planned sale
Price
15.00
Quantity 15,294 -19.8%
Value US$229,410
3.2
Francis Chris See Remarks Officer
Transaction date
Planned sale
Price
15.09
Quantity 17,900 -22.4%
Value US$270,183
3.2
BOLNO PAUL President and CEO Executive Director
Transaction date
Sale
Price
13.45
Quantity 10,480 -3.7%
Value US$140,956
3.2
Francis Chris See Remarks Officer
Transaction date
Sale
Price
13.45
Quantity 1,883 -3.0%
Value US$25,326
3.2
Vargeese Chandra See Remarks Officer
Transaction date
Sale
Price
13.45
Quantity 3,228 -0.8%
Value US$43,417
3.2
Moran Kyle Chief Financial Officer Officer
Transaction date
Sale
Price
13.45
Quantity 3,588 -2.6%
Value US$48,259
3.2
KYLE MORAN Officer Officer
Transaction date
Proposed sale
Price
13.45
Quantity 3,564
Value US$47,936
3.2
PAUL BOLNO Officer Officer
Transaction date
Proposed sale
Price
13.45
Quantity 10,411
Value US$140,028
3.2
Chris Francis Officer Officer
Transaction date
Proposed sale
Price
13.45
Quantity 1,870
Value US$25,152
3.2
Francis Chris See Remarks Officer
Transaction date
Planned sale
Price
16.70
Quantity 1,295 -4.9%
Value US$21,626
3.2
Francis Chris See Remarks Officer
Transaction date
Planned sale
Price
15.92
Quantity 8,080 -23.5%
Value US$128,634
2.3
GSK plc Large shareholder
Transaction date
Purchase
Price
19.00
Quantity 1,470,000 +8.8%
Value US$27,930,000
3.2
Moran Kyle Chief Financial Officer Officer
Transaction date
Planned sale
Price
20.03
Quantity 50,000 -35.6%
Value US$1,001,250
3.2
Moran Kyle Chief Financial Officer Officer
Transaction date
Planned sale
Price
20.25
Quantity 36 -0.0%
Value US$729
3.2
KYLE MORAN Officer Officer
Transaction date
Proposed sale
Price
18.52
Quantity 86,000
Value US$1,592,720
Wagner Heidi L Non-Executive Director
Transaction date
Planned sale
Price
14.00
Quantity 7,000 -13.5%
Value US$98,000
Wagner Heidi L Non-Executive Director
Transaction date
Planned sale
Price
13.00
Quantity 7,000 -13.5%
Value US$91,000
Verdine Gregory L. Non-Executive Director
Transaction date
Planned sale
Price
14.05
Quantity 7,980 -2.8%
Value US$112,119
Verdine Gregory L. Non-Executive Director
Transaction date
Planned sale
Price
13.09
Quantity 12,020 -4.1%
Value US$157,342
3.2
Moran Kyle Chief Financial Officer Officer
Transaction date
Planned sale
Price
18.00
Quantity 50,000 -35.9%
Value US$900,000
3.2
Moran Kyle Chief Financial Officer Officer
Transaction date
Planned sale
Price
13.20
Quantity 50,000 -35.9%
Value US$660,000
3.2
Moran Kyle Chief Financial Officer Officer
Transaction date
Planned sale
Price
15.00
Quantity 50,000 -26.4%
Value US$750,000
3.2
Moran Kyle Chief Financial Officer Officer
Transaction date
Planned sale
Price
13.20
Quantity 60,000 -40.2%
Value US$792,000
4.1
HENRY CHRISTIAN O Non-Executive Director
Transaction date
Planned sale
Price
18.02
Quantity 30,000 -70.3%
Value US$540,600
4.1
HENRY CHRISTIAN O Non-Executive Director
Transaction date
Planned sale
Price
14.07
Quantity 15,000 -54.2%
Value US$211,050
4.1
HENRY CHRISTIAN O Non-Executive Director
Transaction date
Planned sale
Price
12.75
Quantity 42,000 -76.8%
Value US$535,500
4.1
HENRY CHRISTIAN O Non-Executive Director
Transaction date
Planned sale
Price
12.75
Quantity 6,445 -33.7%
Value US$82,174
3.3
CORRIGAN MARK Non-Executive Director
Transaction date
Planned sale
Price
14.07
Quantity 6,515 -18.4%
Value US$91,633
3.3
CORRIGAN MARK Non-Executive Director
Transaction date
Planned sale
Price
13.09
Quantity 9,600 -21.4%
Value US$125,664
2.9
Rawcliffe Adrian Non-Executive Director
Transaction date
Planned sale
Price
15.00
Quantity 42,000 -76.8%
Value US$630,000
3.2
Francis Chris See Remarks Officer
Transaction date
Planned sale
Price
14.08
Quantity 22,500 -47.4%
Value US$316,800
3.2
Francis Chris See Remarks Officer
Transaction date
Planned sale
Price
16.00
Quantity 50,000 -66.7%
Value US$800,000
3.2
Francis Chris See Remarks Officer
Transaction date
Planned sale
Price
14.20
Quantity 122,349 -83.0%
Value US$1,736,744
3.2
Francis Chris See Remarks Officer
Transaction date
Planned sale
Price
15.00
Quantity 17,900 -41.7%
Value US$268,500
3.2
Francis Chris See Remarks Officer
Transaction date
Planned sale
Price
14.08
Quantity 37,500 -60.0%
Value US$528,000
3.2
Francis Chris See Remarks Officer
Transaction date
Planned sale
Price
15.00
Quantity 9,375 -27.3%
Value US$140,625
3.2
Francis Chris See Remarks Officer
Transaction date
Planned sale
Price
14.50
Quantity 45,882 -64.7%
Value US$665,289
3.2
Francis Chris See Remarks Officer
Transaction date
Planned sale
Price
14.56
Quantity 107,400 -81.1%
Value US$1,563,314
3.2
Francis Chris See Remarks Officer
Transaction date
Planned sale
Price
14.50
Quantity 28,125 -52.9%
Value US$407,812
Tan Aik Na Non-Executive Director
Transaction date
Planned sale
Price
12.75
Quantity 21,000 -45.3%
Value US$267,750
Tan Aik Na Non-Executive Director
Transaction date
Planned sale
Price
12.75
Quantity 21,000 -45.3%
Value US$267,750
Tan Aik Na Non-Executive Director
Transaction date
Planned sale
Price
15.00
Quantity 25,000 -49.6%
Value US$375,000
Tan Aik Na Non-Executive Director
Transaction date
Planned sale
Price
12.75
Quantity 20,000 -28.4%
Value US$255,000
Tan Aik Na Non-Executive Director
Transaction date
Planned sale
Price
15.00
Quantity 17,230 -40.4%
Value US$258,450
Tan Aik Na Non-Executive Director
Transaction date
Planned sale
Price
12.75
Quantity 15,000 -26.0%
Value US$191,250
Tan Aik Na Non-Executive Director
Transaction date
Planned sale
Price
15.00
Quantity 7,494 -22.8%
Value US$112,410
Tan Aik Na Non-Executive Director
Transaction date
Planned sale
Price
12.75
Quantity 7,494 -18.6%
Value US$95,548
4.1
Henry Family Trust Affiliate
Transaction date
Proposed sale
Price
18.52
Quantity 93,445
Value US$1,730,601
HEIDI L WAGNER Director Non-Executive Director
Transaction date
Proposed sale
Price
7.49
Quantity 14,000
Value US$104,860
3.2
KYLE MORAN Officer Officer
Transaction date
Proposed sale
Price
7.49
Quantity 210,000
Value US$1,572,900
3.2
CHRISTOPHER FRANCIS Officer Officer
Transaction date
Proposed sale
Price
7.49
Quantity 483,602
Value US$3,622,179
GREGORY VERDINE Director Non-Executive Director
Transaction date
Proposed sale
Price
7.49
Quantity 20,000
Value US$149,800
2.9
ADRIAN RAWCLIFFE Director Non-Executive Director
Transaction date
Proposed sale
Price
7.49
Quantity 42,000
Value US$314,580
3.3
MARK CORRIGAN Director Non-Executive Director
Transaction date
Proposed sale
Price
7.49
Quantity 16,115
Value US$120,701
AIK NA TAN Director Non-Executive Director
Transaction date
Proposed sale
Price
13.58
Quantity 134,218
Value US$1,823,158
2.9
Rawcliffe Adrian Non-Executive Director
Transaction date
Planned sale
Price
6.79
Quantity 16,115 -55.9%
Value US$109,421
2.9
RA CAPITAL MANAGEMENT, L.P. Non-Executive Director Large shareholder
Transaction date
Purchase
Price
6.69
Quantity 1,000 +0.0%
Value US$6,688
2.9
ADRIAN RAWCLIFFE Director Non-Executive Director
Transaction date
Proposed sale
Price
6.96
Quantity 16,115
Value US$112,080
Verdine Gregory L. Non-Executive Director
Transaction date
Planned sale
Price
10.00
Quantity 10,000 -3.4%
Value US$100,000
3.2
BOLNO PAUL President and CEO Executive Director
Transaction date
Planned sale
Price
10.10
Quantity 217,351 -64.2%
Value US$2,194,810
3.2
PAUL BOLNO Director; Officer Executive Director
Transaction date
Proposed sale
Price
9.76
Quantity 217,351
Value US$2,121,346
GREGORY VERDINE Director Non-Executive Director
Transaction date
Proposed sale
Price
9.76
Quantity 25,000
Value US$244,000
Tan Aik Na Non-Executive Director
Transaction date
Planned sale
Price
9.25
Quantity 21,000 -34.2%
Value US$194,250
AIK NA TAN Director Non-Executive Director
Transaction date
Proposed sale
Price
9.25
Quantity 21,000
Value US$194,250
4.1
Christian Henry Director Non-Executive Director
Transaction date
Proposed sale
Price
7.70
Quantity 9,670
Value US$74,459
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-13 2026-08-12 PlS Planned sale
2.9
Rawcliffe Adrian
Non-Executive Director
7,410 -25.5%
46.34
US$3,132,121 		7,410 -25.5% 46.34 US$3,132,121
2026-08-12 2026-08-12 PrS Proposed sale
2.9
ADRIAN G RAWCLIFFE

Director

Non-Executive Director
2,201
114.95
US$2,152,124 		2,201 114.95 US$2,152,124
2026-08-13 2026-08-11 PlS Planned sale
1.4
TAKANASHI KEN
Non-Executive Director
18,587 -28.0%
259.89
US$3,106,211 		18,587 -28.0% 259.89 US$3,106,211
2026-08-13 2026-08-11 PlS Planned sale
Wagner Heidi L
Non-Executive Director
7,000 -13.5%
6.01
US$42,070 		7,000 -13.5% 6.01 US$42,070
2026-08-13 2026-08-11 PlS Planned sale
Tan Aik Na
Non-Executive Director
432 -1.7%
6.01
US$2,596 		432 -1.7% 6.01 US$2,596
2026-08-11 2026-08-11 PrS Proposed sale
HEIDI L WAGNER

Director

Non-Executive Director
7,000
6.07
US$42,490 		7,000 6.07 US$42,490
2026-03-30 2026-03-30 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
971,091 +3.7%
6.50
US$6,312,092 		971,091 +3.7% 6.50 US$6,312,092
2026-03-30 2026-03-27 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
2,495,623 +10.6%
6.43
US$16,046,856 		2,495,623 +10.6% 6.43 US$16,046,856
2026-03-30 2026-03-26 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
351,224 +1.5%
6.38
US$2,240,809 		351,224 +1.5% 6.38 US$2,240,809
2026-03-30 2026-03-26 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
4,954,558 +27.2%
6.06
US$30,024,621 		4,954,558 +27.2% 6.06 US$30,024,621
2026-02-27 2026-02-26 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
15,294 -19.8%
15.00
US$229,410 		15,294 -19.8% 15.00 US$229,410
2026-02-27 2026-02-26 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
17,900 -22.4%
15.09
US$270,183 		17,900 -22.4% 15.09 US$270,183
2026-02-11 2026-02-09 S Sale
3.2
BOLNO PAUL

President and CEO

Executive Director
10,480 -3.7%
13.45
US$140,956 		10,480 -3.7% 13.45 US$140,956
2026-02-11 2026-02-09 S Sale
3.2
Francis Chris

See Remarks

Officer
1,883 -3.0%
13.45
US$25,326 		1,883 -3.0% 13.45 US$25,326
2026-02-11 2026-02-09 S Sale
3.2
Vargeese Chandra

See Remarks

Officer
3,228 -0.8%
13.45
US$43,417 		3,228 -0.8% 13.45 US$43,417
2026-02-11 2026-02-09 S Sale
3.2
Moran Kyle

Chief Financial Officer

Officer
3,588 -2.6%
13.45
US$48,259 		3,588 -2.6% 13.45 US$48,259
2026-02-09 2026-02-09 PrS Proposed sale
3.2
KYLE MORAN

Officer

Officer
3,564
13.45
US$47,936 		3,564 13.45 US$47,936
2026-02-09 2026-02-09 PrS Proposed sale
3.2
PAUL BOLNO

Officer

Officer
10,411
13.45
US$140,028 		10,411 13.45 US$140,028
2026-02-09 2026-02-09 PrS Proposed sale
3.2
Chris Francis

Officer

Officer
1,870
13.45
US$25,152 		1,870 13.45 US$25,152
2026-01-06 2026-01-02 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
1,295 -4.9%
16.70
US$21,626 		1,295 -4.9% 16.70 US$21,626
2026-01-06 2026-01-02 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
8,080 -23.5%
15.92
US$128,634 		8,080 -23.5% 15.92 US$128,634
2025-12-15 2025-12-11 B Purchase
2.3
GSK plc
Large shareholder
1,470,000 +8.8%
19.00
US$27,930,000 		1,470,000 +8.8% 19.00 US$27,930,000
2025-12-10 2025-12-09 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
50,000 -35.6%
20.03
US$1,001,250 		50,000 -35.6% 20.03 US$1,001,250
2025-12-10 2025-12-09 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
36 -0.0%
20.25
US$729 		36 -0.0% 20.25 US$729
2025-12-09 2025-12-09 PrS Proposed sale
3.2
KYLE MORAN

Officer

Officer
86,000
18.52
US$1,592,720 		86,000 18.52 US$1,592,720
2025-12-10 2025-12-08 PlS Planned sale
Wagner Heidi L
Non-Executive Director
7,000 -13.5%
14.00
US$98,000 		7,000 -13.5% 14.00 US$98,000
2025-12-10 2025-12-08 PlS Planned sale
Wagner Heidi L
Non-Executive Director
7,000 -13.5%
13.00
US$91,000 		7,000 -13.5% 13.00 US$91,000
2025-12-10 2025-12-08 PlS Planned sale
Verdine Gregory L.
Non-Executive Director
7,980 -2.8%
14.05
US$112,119 		7,980 -2.8% 14.05 US$112,119
2025-12-10 2025-12-08 PlS Planned sale
Verdine Gregory L.
Non-Executive Director
12,020 -4.1%
13.09
US$157,342 		12,020 -4.1% 13.09 US$157,342
2025-12-10 2025-12-08 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
50,000 -35.9%
18.00
US$900,000 		50,000 -35.9% 18.00 US$900,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
50,000 -35.9%
13.20
US$660,000 		50,000 -35.9% 13.20 US$660,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
50,000 -26.4%
15.00
US$750,000 		50,000 -26.4% 15.00 US$750,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Moran Kyle

Chief Financial Officer

Officer
60,000 -40.2%
13.20
US$792,000 		60,000 -40.2% 13.20 US$792,000
2025-12-10 2025-12-08 PlS Planned sale
4.1
HENRY CHRISTIAN O
Non-Executive Director
30,000 -70.3%
18.02
US$540,600 		30,000 -70.3% 18.02 US$540,600
2025-12-10 2025-12-08 PlS Planned sale
4.1
HENRY CHRISTIAN O
Non-Executive Director
15,000 -54.2%
14.07
US$211,050 		15,000 -54.2% 14.07 US$211,050
2025-12-10 2025-12-08 PlS Planned sale
4.1
HENRY CHRISTIAN O
Non-Executive Director
42,000 -76.8%
12.75
US$535,500 		42,000 -76.8% 12.75 US$535,500
2025-12-10 2025-12-08 PlS Planned sale
4.1
HENRY CHRISTIAN O
Non-Executive Director
6,445 -33.7%
12.75
US$82,174 		6,445 -33.7% 12.75 US$82,174
2025-12-10 2025-12-08 PlS Planned sale
3.3
CORRIGAN MARK
Non-Executive Director
6,515 -18.4%
14.07
US$91,633 		6,515 -18.4% 14.07 US$91,633
2025-12-10 2025-12-08 PlS Planned sale
3.3
CORRIGAN MARK
Non-Executive Director
9,600 -21.4%
13.09
US$125,664 		9,600 -21.4% 13.09 US$125,664
2025-12-10 2025-12-08 PlS Planned sale
2.9
Rawcliffe Adrian
Non-Executive Director
42,000 -76.8%
15.00
US$630,000 		42,000 -76.8% 15.00 US$630,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
22,500 -47.4%
14.08
US$316,800 		22,500 -47.4% 14.08 US$316,800
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
50,000 -66.7%
16.00
US$800,000 		50,000 -66.7% 16.00 US$800,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
122,349 -83.0%
14.20
US$1,736,744 		122,349 -83.0% 14.20 US$1,736,744
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
17,900 -41.7%
15.00
US$268,500 		17,900 -41.7% 15.00 US$268,500
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
37,500 -60.0%
14.08
US$528,000 		37,500 -60.0% 14.08 US$528,000
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
9,375 -27.3%
15.00
US$140,625 		9,375 -27.3% 15.00 US$140,625
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
45,882 -64.7%
14.50
US$665,289 		45,882 -64.7% 14.50 US$665,289
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
107,400 -81.1%
14.56
US$1,563,314 		107,400 -81.1% 14.56 US$1,563,314
2025-12-10 2025-12-08 PlS Planned sale
3.2
Francis Chris

See Remarks

Officer
28,125 -52.9%
14.50
US$407,812 		28,125 -52.9% 14.50 US$407,812
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
21,000 -45.3%
12.75
US$267,750 		21,000 -45.3% 12.75 US$267,750
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
21,000 -45.3%
12.75
US$267,750 		21,000 -45.3% 12.75 US$267,750
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
25,000 -49.6%
15.00
US$375,000 		25,000 -49.6% 15.00 US$375,000
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
20,000 -28.4%
12.75
US$255,000 		20,000 -28.4% 12.75 US$255,000
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
17,230 -40.4%
15.00
US$258,450 		17,230 -40.4% 15.00 US$258,450
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
15,000 -26.0%
12.75
US$191,250 		15,000 -26.0% 12.75 US$191,250
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
7,494 -22.8%
15.00
US$112,410 		7,494 -22.8% 15.00 US$112,410
2025-12-10 2025-12-08 PlS Planned sale
Tan Aik Na
Non-Executive Director
7,494 -18.6%
12.75
US$95,548 		7,494 -18.6% 12.75 US$95,548
2025-12-08 2025-12-08 PrS Proposed sale
4.1
Henry Family Trust

Affiliate
93,445
18.52
US$1,730,601 		93,445 18.52 US$1,730,601
2025-12-08 2025-12-08 PrS Proposed sale
HEIDI L WAGNER

Director

Non-Executive Director
14,000
7.49
US$104,860 		14,000 7.49 US$104,860
2025-12-08 2025-12-08 PrS Proposed sale
3.2
KYLE MORAN

Officer

Officer
210,000
7.49
US$1,572,900 		210,000 7.49 US$1,572,900
2025-12-08 2025-12-08 PrS Proposed sale
3.2
CHRISTOPHER FRANCIS

Officer

Officer
483,602
7.49
US$3,622,179 		483,602 7.49 US$3,622,179
2025-12-08 2025-12-08 PrS Proposed sale
GREGORY VERDINE

Director

Non-Executive Director
20,000
7.49
US$149,800 		20,000 7.49 US$149,800
2025-12-08 2025-12-08 PrS Proposed sale
2.9
ADRIAN RAWCLIFFE

Director

Non-Executive Director
42,000
7.49
US$314,580 		42,000 7.49 US$314,580
2025-12-08 2025-12-08 PrS Proposed sale
3.3
MARK CORRIGAN

Director

Non-Executive Director
16,115
7.49
US$120,701 		16,115 7.49 US$120,701
2025-12-08 2025-12-08 PrS Proposed sale
AIK NA TAN

Director

Non-Executive Director
134,218
13.58
US$1,823,158 		134,218 13.58 US$1,823,158
2025-11-14 2025-11-13 PlS Planned sale
2.9
Rawcliffe Adrian
Non-Executive Director
16,115 -55.9%
6.79
US$109,421 		16,115 -55.9% 6.79 US$109,421
2025-11-14 2025-11-13 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Non-Executive Director Large shareholder
1,000 +0.0%
6.69
US$6,688 		1,000 +0.0% 6.69 US$6,688
2025-11-13 2025-11-13 PrS Proposed sale
2.9
ADRIAN RAWCLIFFE

Director

Non-Executive Director
16,115
6.96
US$112,080 		16,115 6.96 US$112,080
2025-08-26 2025-08-22 PlS Planned sale
Verdine Gregory L.
Non-Executive Director
10,000 -3.4%
10.00
US$100,000 		10,000 -3.4% 10.00 US$100,000
2025-08-26 2025-08-22 PlS Planned sale
3.2
BOLNO PAUL

President and CEO

Executive Director
217,351 -64.2%
10.10
US$2,194,810 		217,351 -64.2% 10.10 US$2,194,810
2025-08-22 2025-08-22 PrS Proposed sale
3.2
PAUL BOLNO

Director; Officer

Executive Director
217,351
9.76
US$2,121,346 		217,351 9.76 US$2,121,346
2025-08-22 2025-08-22 PrS Proposed sale
GREGORY VERDINE

Director

Non-Executive Director
25,000
9.76
US$244,000 		25,000 9.76 US$244,000
2025-08-19 2025-08-15 PlS Planned sale
Tan Aik Na
Non-Executive Director
21,000 -34.2%
9.25
US$194,250 		21,000 -34.2% 9.25 US$194,250
2025-08-15 2025-08-15 PrS Proposed sale
AIK NA TAN

Director

Non-Executive Director
21,000
9.25
US$194,250 		21,000 9.25 US$194,250
2025-08-13 2025-08-13 PrS Proposed sale
4.1
Christian Henry

Director

Non-Executive Director
9,670
7.70
US$74,459 		9,670 7.70 US$74,459
Explore more

More insider trading research around WAVE Life Sciences Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America